← Back to Search

Nudges for MRI Screening in Women with Dense Breasts

N/A

Waitlist Available

Led By Anne Marie McCarthy, PhD

Research Sponsored by Abramson Cancer Center at Penn Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Provider needs to have ordered the initial screening mammogram

Women aged 40-74

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial aims to boost MRI use in women with dense breasts & explore if nudging providers & patients can help, while accounting for racial differences.

Who is the study for?

This trial is for women aged 40-74 with extremely dense breasts who had a non-actionable mammogram within the last 6 months at specified Penn Medicine locations. They must have a valid mobile number, and their provider should have ordered the initial mammogram. Women with prior breast cancer or recent MRI/ultrasound are excluded.Check my eligibility

What is being tested?

The study tests if 'nudges' to either patients, providers, or both can increase breast MRI screenings among women with very dense breasts. It also examines if there's a difference in response between Black and White women.See study design

What are the potential side effects?

Since this trial involves nudging interventions rather than medical treatments, traditional side effects like those seen with medications are not applicable.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My doctor has ordered my first mammogram.

Select...

I am a woman aged between 40 and 74.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Ordering and/or scheduling of supplemental breast MRI

Secondary outcome measures

Cancer detection rate

Completion of breast MRI

False-positive rate

+2 more

Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Provider nudge onlyExperimental Treatment1 Intervention

Nudge sent to provider through EHR.

Group II: Patient nudge onlyExperimental Treatment1 Intervention

Nudge sent to the patient through text messaging.

Group III: Patient and provider nudgeExperimental Treatment2 Interventions

Nudge sent to both provider through EHR, and to patient through text messaging.

Group IV: Usual care (no nudge)Active Control1 Intervention

Usual standard of care, no nudging.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Abramson Cancer Center at Penn MedicineLead Sponsor

387 Previous Clinical Trials

144,095 Total Patients Enrolled

44 Trials studying Breast Cancer

59,249 Patients Enrolled for Breast Cancer

University of PennsylvaniaLead Sponsor

2,000 Previous Clinical Trials

42,878,488 Total Patients Enrolled

27 Trials studying Breast Cancer

24,760 Patients Enrolled for Breast Cancer

Anne Marie McCarthy, PhDPrincipal InvestigatorUniversity of Pennsylvania

Media Library

Provider nudge only Clinical Trial Eligibility Overview. Trial Name: NCT05787249 — N/A

Breast Cancer Research Study Groups: Usual care (no nudge), Provider nudge only, Patient nudge only, Patient and provider nudge

Breast Cancer Clinical Trial 2023: Provider nudge only Highlights & Side Effects. Trial Name: NCT05787249 — N/A

Provider nudge only 2023 Treatment Timeline for Medical Study. Trial Name: NCT05787249 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What qualifications must be met in order to enroll in this medical research?

"2000 individuals are requested for this trial, all of whom must be between the age range 40-74 and have been medically diagnosed with breast cancer."

Answered by AI

Are participants aged 30 and above eligible for this research trial?

"According to the study's requirements, participants must be between 40 and 74 years old. For patients outside of this age range, there are 66 clinical trials for those 18 or younger and 2,545 studies available for individuals 65 or over."

Answered by AI

Are there any current vacancies for participants in this study?

"Evidently, this particular trial is not actively recruiting. The initial post was made on April 10th 2023 and the latest update came a day later. Nevertheless, there are many other trials currently scouting for participants with 2638 studies listed at clinicaltrials.gov."

Answered by AI

Recent research and studies

JAMA Network OpenJournal

Effect of an Automated Patient Dashboard Using Active Choice and Peer Comparison Performance Feedback to Physicians on Statin Prescribing

Patel, Mitesh S., Gregory W. Kurtzman, Sneha Kannan, Dylan S. Small, Alexander Morris, Steve Honeywell Jr, Damien Leri, et al.. 2018. “Effect of an Automated Patient Dashboard Using Active Choice and Peer Comparison Performance Feedback to Physicians on Statin Prescribing”. JAMA Network Open. American Medical Association (AMA). doi:10.1001/jamanetworkopen.2018.0818.

clinicaltrials.govStudy

Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts

2023. "Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05787249.